Conferences And Talks

Future Presentations

Unfortunately planned talks for International Clinical Trials Day and Pint of Science 2020 have had to be put on hold due to the Coronovirus.

I hope that I will be able to deliver them on the new rescheduled dates, when they are announced.

  • 2021
    20th January

    Managing Pain in People with Arthritis

    3:30 pm

    British Rheumatology Society/Versus Arthritis webinar on managing pain in people with arthritis. I will be part on the panel alongside colleagues from the Versus Arthritis Pain Centre. My dissertation student Mimi Ng, will also be presenting the findings from her MSc Sport and Exercise Medicine study sharing how health professionals can influence whether people in pain will exercise.

Previous Presentations
  • 2020
    11th November

    Research Data Alliance (RDA) Adoption Opportunities & Highlights Session & COVID-19 Panel

    21:00-22:30 UTC
    Location: RDA 16th Plenary Meeting – Costa Rica (Virtual)

    As a co-moderator of the community participation working group, I will be representing the group at the COVID-19 WG Panel Discussion during the RDA Adoption Opportunities & Highlights Session. Aside from providing an overview of our guidelines we shall also discuss how these recommendations can apply outside of the current pandemic.

  • 2020
    8th March

    Celebrating Nottingham Women- International Women Day 2020

    10:30am – 3pm
    Location: Marquee in Nottingham Old Market Square

    The University of Nottingham is to celebrate International Women’s Day 2020 by showcasing the knowledge and expertise of its talented women staff and students at a civic event in Old Market Square, Nottingham.

    The free event which is open to everyone, being jointly hosted with Nottingham Trent University from 10.30am to 2.30pm on Sunday 8 March, will feature fun, interactive activities for all the family offering an insight into some of the amazing work that happens across the university’s campuses.

    In particular, the event aims to inspire young women in Nottingham and challenge the preconceptions and prejudices about gender roles and limitations, particularly around the science, technology, engineering and medical agenda.

    Along with my colleagues and students, I will be presenting activities and information on the science behind great women sporting achievements – how your body works when you exercise and why physical activity is great for your health and wellbeing.

    We will also be showcasing some of our past research and tell you how you can get involved in some of our future studies.

  • 2019
    30th August

    Moving Your Way to Good Health

    9:00 – 18:00
    Location: University of Nottingham

    This conference will show the far-reaching benefits physical activity and healthy eating can have, from reducing cancer, cardiovascular disease, obesity, diabetes, to helping with mental health problems. I will be presenting ‘How active are our patients?’

  • 2019
    27th June

    Patient and Public Involvement in Research: a new module for undergraduate medical students delivered through co-production

    Location: UK Clinical Research Facility (UKCRF) Network 2019 Annual Conference

    I will be presenting our experiences of successfully co-producing and co-delivering a new BMedSci module. Introducing second-year medical students to Patient and Public Involvement (PPI) across the research life cycle, its importance in good research and the benefits gained from a patient perspective. The module was co-produced and co-delivered by staff from the School of Medicine, NIHR Nottingham Biomedical Research Centre (BRC), and members of the public, all part of the East Midlands Sharebank network.

  • 2019
    5th May

    Identifying predictors of placebo response in osteoarthritis clinical trials of three agents with different routes of delivery: a meta-analysis using individual patient data.

    Location: 2019 Osteoarthritis Research Society International (OARSI) World Congress, Toronto, Canada.

    Most drug treatments for osteoarthritis (OA) do not achieve a minimum clinically important difference above placebo and often associate with side-effects. On average, 75% of the analgesic effect from OA treatments in clinical trials, and potentially in clinical practice, can be attributed to placebo/contextual response, though the magnitude of this response may vary greatly between patients. Here I will present results from an individual patient data (IPD) meta-analysis of three contrasting treatments for OA to identify placebo responders and the potential determinants of the placebo response in OA.